Prophylactic In Vivo Hematopoietic Stem Cell Gene Therapy with an Immune Checkpoint Inhibitor Reverses Tumor Growth in Syngeneic Mouse Tumor Models.
Saved in:
| Title: | Prophylactic In Vivo Hematopoietic Stem Cell Gene Therapy with an Immune Checkpoint Inhibitor Reverses Tumor Growth in Syngeneic Mouse Tumor Models. |
|---|---|
| Authors: | Li C; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington., Course MM; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington., McNeish IA; Imperial College, London, United Kingdom., Drescher CW; Fred Hutchinson Cancer Research Center, Seattle, Washington., Valdmanis PN; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington., Lieber A; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington. lieber00@uw.edu.; Department of Pathology, University of Washington, Seattle, Washington. |
| Source: | Cancer research [Cancer Res] 2020 Feb 01; Vol. 80 (3), pp. 549-560. Date of Electronic Publication: 2019 Nov 14. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
